USAA
AIMT

United Services Automobile Association’s Aimmune Therapeutics AIMT Stock Holding History

United Services Automobile Association’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-34,028
Closed -$708K – 2066
2019
Q2 		$708K Buy
34,028
+265
+0.8% +$5.46K ﹤0.01% 1453
2019
Q1 		$755K Hold
33,763
– – ﹤0.01% 1447
2018
Q4 		$808K Sell
33,763
-2,155
-6% -$55.8K ﹤0.01% 1349
2018
Q3 		$980K Sell
35,918
-470
-1% -$13.3K ﹤0.01% 1361
2018
Q2 		$978K Sell
36,388
-817
-2% -$25K ﹤0.01% 1382
2018
Q1 		$1.18M Buy
+37,205
New +$1.31M ﹤0.01% 1297

Other funds holding AIMT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

United Services Automobile Association's AIMT Position: Q3 2019 in Review

United Services Automobile Association sold out of Aimmune Therapeutics (AIMT) in Q3 2019, closing a stake of 34,028 shares — an estimated $708K sold.

United Services Automobile Association first reported a position in AIMT in Q1 2018 and held it in 6 quarters. The position peaked at $1.18M in Q1 2018. 146 funds tracked by Wall St. Rank hold AIMT as of Q3 2019.

  • United Services Automobile Association reported no remaining Aimmune Therapeutics position as of Q3 2019 after selling out during the quarter.
  • United Services Automobile Association sold 34,028 Aimmune Therapeutics shares in Q3 2019, an estimated $708K.
  • United Services Automobile Association first reported a position in Aimmune Therapeutics in Q1 2018 and held it in 6 quarters.
  • United Services Automobile Association's Aimmune Therapeutics position peaked at $1.18M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q3 2019.

Based on United Services Automobile Association's 13F filing for Q3 2019, filed 13 Nov 2019.